Medical Oncology PhD Faculty Member

Screen reader users may encounter difficulty with this site. For assistance with applying, please contact hr-accessibleapplication@osu.edu. If you have questions while submitting an application, please review these frequently asked questions.

Current Employees and Students:

If you are currently employed or enrolled as a student at The Ohio State University, please log in to Workday to use the internal application process.

Welcome to The Ohio State University's career site.  We invite you to apply to positions of interest. In order to ensure your application is complete, you must complete the following:

• Ensure you have all necessary documents available when starting the application process. You can review the additional job description section on postings for documents that may be required. You will be presented with the opportunity to attach up to five (5) documents in the Application Documents section. If necessary, please consider combining documents into one file.

• If you require any assistance with including the necessary documents in the application process, please reach out to HRConnection@osu.edu.

• Resume parsing is not effective on documents which exceed one (1) page.  As a result, it is not recommended to select Autofill with Resume when applying if using a resume or CV which exceeds one (1) page.

• Prior to submitting your application, please review and update (if necessary) the information in your candidate profile as it will transfer to your application. 

Job Title:

Medical Oncology PhD Faculty Member

Department:

Medicine | IM Medical Oncology

The Division of Medical Oncology at The Ohio State University invites applications for a associate track faculty position at the Assistant or Associate Professor level. We seek a dynamic and innovative scientist with a PhD (or MD/PhD) and a strong research focus in cancer biology, immuno-oncology, molecular genetics, or translational oncology. The successful candidate will join a vibrant academic and clinical environment committed to advancing cancer research and improving patient outcomes.

Key Responsibilities

• Develop and lead an independent, externally funded research program in medical oncology or cancer genetics.
• Collaborate with interdisciplinary teams across the OSUCCC – James, including basic scientists, clinicians, and translational researchers.
• Contribute to graduate and medical education through teaching, mentoring, and curriculum development.
• Publish impactful research in peer-reviewed journals and present findings at national and international conferences.
• Participate in departmental and institutional service, including committee work and strategic initiatives.

Minimum Education/Experience Requirements:

PhD or MD/PhD required; Considerable post-doctoral experience in basic research required; considerable experience in oncology required; proven ability to write scientific reports and publish in scientific, peer-reviewed journals preferred; understanding of key components of grant writing and obtaining funding in support of research required; experience with administration of funded research required.  Requires successful completion of a background check. Selected candidate may be requested to complete a pre-employment physical including a drug screen. 

Department/Division Overview

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute expanded in December 2014 to become the 3rd largest cancer hospital in the U.S.  The extraordinary success of this new 398-bed state-of-the-art hospital has resulted in remarkable clinical growth and robust research portfolio. The Ohio State University is currently seeking faculty at the Assistant Professor, Associate Professor and Professor rank for a variety of roles in the areas of basic and translational research.

Features include:

• NCI-designated Comprehensive Cancer Center since 1976
• One of only 11 freestanding cancer hospitals in the U.S.
• Magnet® designation
• One of only four cancer centers funded by the NCI to conduct Phase I and II cancer clinical trials
• Founding member of t